Willow Financial Statements From 2010 to 2025

Stocks . Canada . 
Stock . Willow Biosciences
WLLW Stock  CAD 0.04  0.01  14.29%   
Willow Biosciences financial statements provide useful quarterly and yearly information to potential Willow Biosciences investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Willow Biosciences financial statements helps investors assess Willow Biosciences' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Willow Biosciences' valuation are summarized below:
Gross Profit
-2.1 M
Profit Margin
(2.69)
Market Capitalization
5.8 M
Enterprise Value Revenue
2.3242
Revenue
2.9 M
We have found one hundred twenty available fundamental gauges for Willow Biosciences, which can be analyzed and compared to other ratios and to its peers. Self-guided Investors are advised to confirm Willow Biosciences' prevalent fundamentals against the trend between 2010 and 2025 to make sure the company can sustain itself down the road. As of the 3rd of March 2025, Market Cap is likely to grow to about 11.9 M, while Enterprise Value is likely to drop about 10.2 M.

Willow Biosciences Total Revenue

1.42 Million

Check Willow Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Willow Biosciences' main balance sheet or income statement drivers, such as Interest Expense of 171.5 K, Selling And Marketing Expenses of 20.8 K or Other Operating Expenses of 17.7 M, as well as many indicators such as Price To Sales Ratio of 11.58, Dividend Yield of 0.0 or PTB Ratio of 4.37. Willow financial statements analysis is a perfect complement when working with Willow Biosciences Valuation or Volatility modules.
  
This module can also supplement various Willow Biosciences Technical models . Check out the analysis of Willow Biosciences Correlation against competitors.

Willow Biosciences Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Other Current Liabilities395.6 K368 K444.9 K
Slightly volatile
Total Current Liabilities2.2 M2.1 M1.2 M
Slightly volatile
Common Stock Total Equity100.4 M95.6 M50.2 M
Slightly volatile
Common Stock Shares Outstanding150 M142.9 M51.1 M
Slightly volatile
Total Liabilities2.5 M3.7 M3.7 M
Slightly volatile
Common Stock142.7 M135.9 M57.9 M
Slightly volatile
Total Assets7.2 M7.7 M9.1 M
Slightly volatile
Accounts Payable650.4 K730.2 K735 K
Pretty Stable
Cash4 M3.6 M5.5 M
Slightly volatile
Cash And Short Term Investments4.2 M3.6 M5.8 M
Slightly volatile
Net Receivables127.4 K190.9 K161.6 K
Slightly volatile
Liabilities And Stockholders Equity7.2 M7.7 M9.1 M
Slightly volatile
Non Current Liabilities Total2.3 M1.6 M3.6 M
Pretty Stable
Other Current Assets747.4 K711.9 K290.4 K
Slightly volatile
Total Current Assets4.5 M4.8 M6.3 M
Slightly volatile
Other Stockholder Equity6.9 M8.4 M4 M
Slightly volatile
Property Plant And Equipment Net2.7 M2.8 M2.4 M
Slightly volatile
Non Current Assets Total3.2 M2.9 M2.9 M
Pretty Stable
Property Plant And Equipment Gross15.1 M14.4 M6.1 M
Slightly volatile
Short and Long Term Debt Total2.6 M2.5 M1.2 M
Slightly volatile
Property Plant Equipment2.6 M2.2 M2.3 M
Pretty Stable
Short Term Investments21.9 K23 K362.4 K
Slightly volatile
Cash And Equivalents12.1 M12.7 M8.4 M
Slightly volatile
Short and Long Term Debt61.3 K94.3 K58.5 K
Slightly volatile
Long Term Investments60 K67.5 K73.6 K
Slightly volatile
Other Liabilities19.7 K20.7 K7.5 M
Slightly volatile
Capital Surpluse5.7 M8.4 M4.5 M
Slightly volatile
Capital Lease Obligations1.1 M1.7 M1.2 M
Very volatile
Capital Stock112.2 M135.9 M88.2 M
Slightly volatile
Intangible Assets4.3 K4.5 K4 M
Slightly volatile

Willow Biosciences Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Selling And Marketing Expenses20.8 K21.9 K293.3 K
Slightly volatile
Other Operating Expenses17.7 M16.8 M8.1 M
Slightly volatile
Total Operating Expenses15.5 M14.7 M7.7 M
Slightly volatile
Selling General Administrative7.3 M6.9 M3.6 M
Slightly volatile
Depreciation And Amortization2.2 M2.1 M1.1 M
Slightly volatile
Cost Of Revenue2 M2.1 M5.9 M
Slightly volatile
Interest Income176 K307.1 K114.3 K
Slightly volatile
Research Development6.6 M7.8 M3.4 M
Slightly volatile
Reconciled Depreciation2.1 M1.6 M2.3 M
Very volatile

Willow Biosciences Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow13.3 M12.7 M6.5 M
Slightly volatile
Depreciation2.2 M2.1 M1.1 M
Slightly volatile
Stock Based Compensation781.8 K483 K664 K
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio11.5812.193 K
Pretty Stable
Days Sales Outstanding56.4859.453.2 K
Slightly volatile
Average Payables323 K392.8 K566.3 K
Slightly volatile
Stock Based Compensation To Revenue0.390.4161.7954
Very volatile
Capex To Depreciation0.370.39160
Slightly volatile
EV To Sales10.6611.222.6 K
Pretty Stable
Inventory Turnover9.059.5325.8906
Slightly volatile
Days Of Inventory On Hand41.6339.6517.7937
Slightly volatile
Payables Turnover5.02.67.7503
Slightly volatile
Sales General And Administrative To Revenue5.225.49190
Very volatile
Research And Ddevelopement To Revenue6.346.67102
Pretty Stable
Capex To Revenue0.580.61105
Very volatile
Cash Per Share0.02780.02930.6347
Slightly volatile
Days Payables Outstanding138146891.8 K
Slightly volatile
Income Quality0.440.750.6803
Slightly volatile
Intangibles To Total Assets8.0E-49.0E-40.1173
Slightly volatile
Current Ratio2.552.074.2571
Slightly volatile
Receivables Turnover6.676.351.5887
Slightly volatile
Graham Number0.280.2991.1862
Slightly volatile
Capex Per Share0.00540.005718.901
Slightly volatile
Average Receivables59.1 K62 K52.2 K
Very volatile
Revenue Per Share0.00890.00850.0065
Pretty Stable
Interest Debt Per Share0.02020.02132.5391
Slightly volatile
Debt To Assets0.190.370.2726
Pretty Stable
Operating Cycle1051103.2 K
Slightly volatile
Days Of Payables Outstanding138146891.8 K
Slightly volatile
Ebt Per Ebit1.741.141.5597
Slightly volatile
Long Term Debt To Capitalization0.160.170.7193
Slightly volatile
Total Debt To Capitalization0.50.350.657
Very volatile
Quick Ratio2.521.964.1976
Slightly volatile
Net Income Per E B T0.770.90.9675
Slightly volatile
Cash Ratio2.171.563.5937
Slightly volatile
Days Of Inventory Outstanding41.6339.6517.7937
Slightly volatile
Days Of Sales Outstanding56.4859.453.2 K
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.561.221.3592
Slightly volatile
Fixed Asset Turnover0.450.430.1673
Slightly volatile
Debt Ratio0.190.370.2726
Pretty Stable
Price Sales Ratio11.5812.193 K
Pretty Stable
Asset Turnover0.170.160.0445
Slightly volatile

Willow Biosciences Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap11.9 M11.2 M22.7 M
Pretty Stable

Willow Fundamental Market Drivers

Forward Price Earnings67.5676
Cash And Short Term Investments3.2 M

About Willow Biosciences Financial Statements

Willow Biosciences investors utilize fundamental indicators, such as revenue or net income, to predict how Willow Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue144.9 K152.1 K
Cost Of Revenue2.1 M2 M
Total Revenue1.3 M1.4 M
Stock Based Compensation To Revenue 0.41  0.39 
Sales General And Administrative To Revenue 5.49  5.22 
Research And Ddevelopement To Revenue 6.67  6.34 
Capex To Revenue 0.61  0.58 
Revenue Per Share 0.01  0.01 
Ebit Per Revenue(10.12)(10.63)

Pair Trading with Willow Biosciences

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Willow Biosciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Willow Biosciences will appreciate offsetting losses from the drop in the long position's value.

Moving against Willow Stock

  0.8JPM JPMorgan ChasePairCorr
  0.77TD Toronto Dominion BankPairCorr
  0.48CAE CAE IncPairCorr
  0.44GOOG Alphabet CDRPairCorr
  0.33SOU Southern Energy CorpPairCorr
The ability to find closely correlated positions to Willow Biosciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Willow Biosciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Willow Biosciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Willow Biosciences to buy it.
The correlation of Willow Biosciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Willow Biosciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Willow Biosciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Willow Biosciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Other Information on Investing in Willow Stock

Willow Biosciences financial ratios help investors to determine whether Willow Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Willow with respect to the benefits of owning Willow Biosciences security.
Balance Sheet
Statement
Details
Profit & Loss
Statement
Details
Cash Flow
Statement
Details
Financial
Indicators
Details
Valuation
Indicators
Details
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY